Cansino announced that the company's adsorbed acelless haemophilus influenzae type b type b and acyW135 meningococcus combination vaccine recently officially launched a phase I clinical trial and completed the enrollment of the first test subjects.

Cansino announced that the company's adsorbed acelless haemophilus influenzae type b type b and acyW135 meningococcus combination vaccine recently officially launched a phase I clinical trial and completed the enrollment of the first test subjects.